Akers Biosciences Inc (LSE:AKR) - Share price - Overview

Stock Report

Akers Biosciences Inc AKR

Last Price
GBX65.00

Day Change
-10.00|-13.33%

As of 20/09/2017
10:48:17 BST | GBX
Minimum 15 Minutes Delay.

Last Close75.00p
Day Range65.00 - 65.00
Mkt Cap6.68Mil
52-Wk Range65.00 - 255.00
Yield %0.00
ISINUS00973E1029
Volume3,268
P/E-1.44
P/S1.61
P/CF-1.14

Share Price

Total Returns 19/09/2017

 Chg (%)  
More ...
Akers Biosciences Inc-6.25 
FTSE 100 TR GBP-0.53
 
Financials
201420152016
More ...
Income Statement
Turnover2.691.382.19
Operating Profit-1.95-6.34-2.47
Net Profit-1.90-6.10-2.45
Reported EPS-40.16-118.47-45.19
Balance Sheet
Current Assets8.394.402.58
Non Current Assets2.311.211.54
Total Assets10.705.614.12
Current Liabilities1.191.131.37
Total Liabilities1.191.131.37
Total Equity9.514.482.74
Cash Flow
Operating Cash Flow-2.37-3.36-3.09
Net Change in Cash0.21-0.04-0.24
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

Akers Biosciences Inc is engaged in the development and sale of disposable diagnostic testing device. The Company develops, manufactures, and supplies rapid, point-of-care screening and testing products.

Sector

Medical Instruments & Supplies

Market Position

1581 of 1837 Companies

Index

Outlook

(15/08/2017) "...we look forward to further commercial progress with the company's OxiChek oxidative stress test which we believe can be a major driver of Akers Bio's profitable growth in the future"

Next Event 14/11/2017

Next Q3 announcement
Ratios
CompSecMkt
More ...
PER (E)0.0020.1416.14
Div Yld (E)0.001.614.17
PEG (E)0.002.130.95
ROCE-144.9619.3212.94
Op Mrgn-112.319.97-12.40
EPS Grwth0.0032.6220.07
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.